97国际至尊品牌游戏官网版(中国)有限公司-Official website

CN

Adverse reaction report

MENU

e1_bannerpc.jpg e1_bannerph.jpg
HOME
NEWS

Company news

20220909.jpg

2025.03.26

SinoT and Kalbe Farma have forged a partnership to jointly explore the Southeast Asian market.

SinoT and Kalbe Farma have forged a partnership to jointly explore the Southeast Asian market.

Read More

2025.03.26

SinoT and Kalbe Farma have forged a partnership to jointly explore the Southeast Asian market.

SinoT and Kalbe Farma have forged a partnership to jointly explore the Southeast Asian market.

Read More

2025.03.26

NMPA approves SinoT’s ANDA application for Dapagliflozin and Metformin Hydrochloride Extended-release Tablet

NMPA approves SinoT’s ANDA application for Dapagliflozin and Metformin Hydrochloride Extended-release Tablet

Read More

2025.03.26

Haimen Pharma passed SFDA inspection

Haimen Pharma passed SFDA inspection

Read More

2024.07.03

Haimen Pharma passed PMDA inspection

Haimen Pharma passed PMDA inspection

Read More

2024.07.02

SinoT passed FDA cGMP inspection with no action indicated（NAI）

SinoT passed FDA cGMP inspection with no action indicated（NAI）

Read More

2024.07.01

NMPA approves SinoT’s ANDA application for Olaparib Tablet

NMPA approves SinoT’s ANDA application for Olaparib Tablet

Read More

2024.01.23

Health Canada approves SinoT’s generic drug Posaconazole delayed-release tablets (100mg)

Health Canada approves SinoT’s generic drug Posaconazole delayed-release tablets (100mg)

Read More

2023.11.02

SinoT received tentative approval by FDA for Generic Tofacitinib Extended Release Tablet

On August 8, 2023, U.S. Food and Drug Administration（FDA）tentatively approved SinoT’s ANDA application for Tofacitinib Extended Release Tablet (ANDA #216001).

Read More

2023.06.05

FDA approves SinoT's ANDA application for PREGABALIN EXTENDED-RELEASE TABLETS

Recently，Food and Drug Administration (FDA) approved SinoT’s ANDA（# 214496）application for PREGABALIN EXTENDED-RELEASE TABLETS（82.5 mg, 165 mg, and 330 mg）

Read More

Read More

Shanghai Head Office

86 21-6881-9009

99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

Manufacturing Site in Jiangsu

86 513-8122-1988

No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

CRO/CDMO Service
News
Products
Lauched Drug
Pending Approvals
ABOUT SINOT
Overview
R&D and Manufacturing
Contact Us
Career
Talent Recruitment
Talent Development and Motivations
Staff activities
Links
Haimen Pharm
Vastpro
D-innovation
qrcode.jpg

Focus on us

Copyright © 2014-2022 SINOTHERAPEUTICS.COM ICP：13048014-1   Powered by Yongsy

Privacy Legal